The effectiveness of two anti-Id mAbs, mAb 3H1 (CeaVac) and 11D10 (TriAb), which are designed to mimic carcinoembryonic antigen (CEA) and human milk fat globule protein (HMGF), respectively, was assessed in lung cancer patients. This evidence concerns the gene CEACAM5 and lung cancer.